In this article, Chris Gale, vice president, Greentarget, talks pharma, wearables and the necessity of community to make it all work.
Digital health
Pharmaceutical makers have a patient engagement problem. Wearable makers have a user engagement problem. Each could be the other’s solution. But first they need to understand exactly what they need to offer patients. It may be heresy, but clinical outcomes may not be the top priority. Studying employer driven programmes suggests wearable adoption today is not necessarily driven by clinical results, but rather for engagement. And the foundation of engagement is community.